Prognostic factors and outcomes in endometrial stromal sarcoma with the 2009 FIGO staging system: A multicenter review of 114 cases
- 1 January 2014
- journal article
- research article
- Published by Elsevier in Gynecologic Oncology
- Vol. 132 (1) , 70-75
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- The treatment of uterine sarcomasAnnals of Oncology, 2012
- Endometrial stromal sarcoma: Analysis of recurrence following adjuvant treatmentGynecologic Oncology, 2012
- Impact of adjuvant treatment modalities on the management of patients with stages I–II endometrial stromal sarcomaAnnals of Oncology, 2010
- Stage IA vs. IB endometrial stromal sarcoma: Does the new staging system predict survival?Gynecologic Oncology, 2010
- Uterine sarcomas: A reviewGynecologic Oncology, 2010
- The management of patients with uterine sarcoma: A debated clinical challengeCritical Reviews in Oncology/Hematology, 2008
- Low grade Endometrial Stromal Sarcoma of uterine corpus, a clinico-pathological and survey study in 14 casesWorld Journal of Surgical Oncology, 2006
- Ovarian Preservation in Stage I Low-Grade Endometrial Stromal SarcomasObstetrics & Gynecology, 2005
- Low-grade endometrial stromal sarcoma: hormonal aspects☆Gynecologic Oncology, 2003
- Mesenchymal tumors of the uterus. I. A clinical and pathological study of 53 endometrial stromal tumorsCancer, 1966